This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk A/s. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: The Innovations of Josef Vagner
Introduction
Josef Vagner is a notable inventor based in Vaerloese, Denmark. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that inhibit Protein Tyrosine Phosphatases (PTPases). His work is essential for advancing therapeutic options in various medical conditions.
Latest Patents
Josef Vagner holds a patent for "Modulators of protein tyrosine phosphatases (PTPases)." This invention provides novel compounds of Formula 1, which are pharmacologically useful inhibitors of PTPases such as PTP1B, CD45, SHP-1, SHP-2, PTPα, LAR, and HePTP. The patent outlines the compounds, compositions containing these compounds, methods of their use, and methods of their manufacture. He has 1 patent to his name.
Career Highlights
Vagner is currently employed at Novo Nordisk A/S, a leading global healthcare company. His role involves research and development in the field of pharmacology, where he applies his expertise to create innovative solutions for health challenges.
Collaborations
Josef has collaborated with esteemed colleagues such as Lutz Stefan Richter and Henrik Sune Andersen. These partnerships have enhanced his research and contributed to the advancement of their shared goals in the pharmaceutical industry.
Conclusion
Josef Vagner's contributions to the field of pharmacology through his innovative patents and collaborations highlight his importance as an inventor. His work continues to pave the way for new therapeutic options in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile